Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders - Aix-Marseille Université Access content directly
Journal Articles Revue Neurologique Year : 2018

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders

C. Papeix

Domains

Immunotherapy
No file

Dates and versions

hal-03538511 , version 1 (21-01-2022)

Identifiers

Cite

J. Ciron, B. Audoin, B. Bourre, David Brassat, R. Marignier, et al.. Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders. Revue Neurologique, 2018, 174 (4), pp.255-264. ⟨10.1016/j.neurol.2017.11.005⟩. ⟨hal-03538511⟩
27 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More